文献速递疼痛医学神经外科与老年麻醉

蛋白激酶G信号通路通过调节ATP敏感性钾通道参与交感维持性疼痛

Protein kinase G signaling pathway is involved in sympathetically maintained pain by modulating ATP-sensitive potassium channels.
PubMed 文献 · Reg Anesth Pain Med · 2021-09-07

该研究在小鼠尾部躯干横断(CTT)神经病理性疼痛模型中,探索去甲肾上腺素经cGMP-PKG通路增加小直径背根神经节(DRG)神经元兴奋性的机制。行为学显示CTT小鼠出现机械和热超敏反应,可被胍乙啶减轻;抑制cGMP-PKG通路可减弱交感敏感性增高,而cGMP激活剂则增强之。PKG对ATP敏感性钾通道的磷酸化可能介导了去甲肾上腺素对DRG神经元兴奋性的调节。

要点

  • CTT小鼠模型可模拟交感维持性疼痛,表现为机械和热超敏反应及DRG交感神经纤维异常芽生。
  • 去甲肾上腺素通过cGMP-PKG通路增加小直径DRG神经元兴奋性,抑制该通路可减轻交感敏感性。
  • PKG诱导的ATP敏感性钾通道磷酸化可能介导去甲肾上腺素对DRG神经元兴奋性的调节。

核心结论

  • cGMP-PKG信号通路在小直径DRG神经元对去甲肾上腺素兴奋性增高中有重要作用,涉及PKG诱导的ATP敏感性钾通道磷酸化抑制钾电流。
  • 靶向该通路的药物可能有助于治疗交感维持性疼痛。

研究设计与样本

  • 在小鼠中建立尾部躯干横断(CTT)神经病理性疼痛模型。
  • 采用免疫荧光染色、小干扰RNA、药理学和电生理学研究验证假说。

主要发现

  • CTT小鼠出现机械和热超敏反应,腹腔注射胍乙啶可减轻。
  • CTT小鼠DRG中酪氨酸羟化酶阳性神经纤维异常芽生,小直径DRG神经元对去甲肾上腺素的兴奋性增加。
  • 用小干扰RNA和KT5823抑制cGMP-PKG通路可减弱CTT小鼠交感敏感性增高。
  • cGMP激活剂Sp-cGMP和8-Br-cGMP进一步增加交感敏感性。
  • PKG下游靶点ATP敏感性钾通道的磷酸化可能参与去甲肾上腺素对DRG神经元兴奋性的调节。

临床怎么用

  • cGMP-PKG通路及ATP敏感性钾通道可能成为交感维持性疼痛的潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sympathetically maintained pain (SMP) involves an increased excitability of dorsal root ganglion (DRG) neurons to sympathetic nerve stimulation and circulating norepinephrine. The current treatment of SMP has limited efficacy, and hence more mechanistic insights into this intractable pain condition are urgently needed. METHODS: A caudal trunk transection (CTT) model of neuropathic pain was established in mice.Immunofluorescence staining, small interfering RNA, pharmacological and electrophysiological studies were conducted to test the hypothesis that norepinephrine increases the excitability of small-diameter DRG neurons from CTT mice through the activation of cyclic guanosine monophosphate-protein kinase G (cGMP-PKG) signaling pathway. RESULTS: Behavior study showed that CTT mice developed mechanical and heat hypersensitivities, which were attenuated by intraperitoneal injection of guanethidine. CTT mice also showed an abnormal sprouting of tyrosine hydroxylase-positive nerve fibers in DRG, and an increased excitability of small-diameter DRG neurons to norepinephrine, suggesting that CTT is a useful model to study SMP. Importantly, inhibiting cGMP-PKG pathway with small interfering RNA and KT5823 attenuated the increased sympathetic sensitivity in CTT mice. In contrast, cGMP activators (Sp-cGMP, 8-Br-cGMP) further increased sympathetic sensitivity. Furthermore, phosphorylation of ATP-sensitive potassium channel, which is a downstream target of PKG, may contribute to the adrenergic modulation of DRG neuron excitability. CONCLUSIONS: Our findings suggest an important role of cGMP-PKG signaling pathway in the increased excitability of small-diameter DRG neurons to norepinephrine after CTT, which involves an inhibition of the ATP-sensitive potassium currents through PKG-induced phosphorylation. Accordingly, drugs targeting this pathway may help to treat SMP.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Li H, Shang M, Liu L, et al. Protein kinase G signaling pathway is involved in sympathetically maintained pain by modulating ATP-sensitive potassium channels. Reg Anesth Pain Med. 2021. PMID: 34493624. doi:10.1136/rapm-2021-102539

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。